Huey-Ling Chen

Huey-Ling Chen

Auto-generated profile, based on publicly available information

Huey-Ling Chen

Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in Gastroenterology
Verified
Journal Article
Closed access
YNYen–Hsuan Ni
Yen–Hsuan Ni
LHLi-Min Huang
Li-Min Huang
MCMei-Hwei Chang
Mei-Hwei Chang
CYChung–Jen Yen
Chung–Jen Yen
CLChun-Yi Lu
Chun-Yi Lu
DCDing–Shinn Chen
Ding–Shinn Chen

20 December 2007 in Hepatology
Verified
Journal Article
Open access
PDF file
CHCheng-Hui Hsiao
Cheng-Hui Hsiao
MCMei-Hwei Chang
Mei-Hwei Chang
HCHuey-Ling Chen
Huey-Ling Chen
HLHung-Chang Lee
Hung-Chang Lee
TWTzee-Chung Wu
Tzee-Chung Wu
TGTaiwan Infant Stool Color Card Study Group
Taiwan Infant Stool Color Card Study Group
Biliary atresia is the most common cause of death from liver disease in children. Although the Kasai operation before 60 days of age can significantly improve prognosis, delay in referral and surgery remains a formidable problem worldwide because of difficulties in differentiating it from benign prolonged neonatal jaundice. We established a universal screening system using an infant stool color card to promote the early diagnosis and treatment of biliary atresia. After a pilot regional study in 2002–2003, a national stool color screening system was established by integrating the infant stool color card into the child health booklet given to every neonate in Taiwan since 2004. Within 24 hours of the discovery of an abnormal stool color, this event is reported to the registry center. The annual incidence of biliary atresia per 10,000 live births in 2004 and 2005 was 1.85 (40/216,419) and 1.70 (35/205,854), respectively. The sensitivity of detecting biliary atresia using stool cards before 60 days of age was 72.5% in 2004, which improved to 97.1% in 2005. The national rate of the Kasai operation before 60 days of age increased from 60% in 2004 to 74.3% in 2005. The jaundice‐free rate (<2 mg/dL) at 3 months after the Kasai operation among infants with biliary atresia in 2004–2005 was 59.5% (44 of 74), significantly higher than the historical data of 37.0% in 1976–2000 before the stool card screening program (P = 0.002). Conclusion: Universal screening using the stool color cards can enhance earlier referral, which may ultimately lead to timely performance of the Kasai operation and better postoperative outcome in infants with biliary atresia. (HEPATOLOGY 2008.)

1 July 2013 in Journal of Hepatology
Verified
Journal Article
Closed access
WWWan-Hsin Wen
Wan-Hsin Wen
MCMei-Hwei Chang
Mei-Hwei Chang
LZLu-Lu Zhao
Lu-Lu Zhao
YNYen-Hsuan Ni
Yen-Hsuan Ni
HHHong-Yuan Hsu
Hong-Yuan Hsu
HCHuey-Ling Chen
Huey-Ling Chen

1 April 2012 in Gastroenterology
Verified
Journal Article
Closed access
HCHuey–Ling Chen
Huey–Ling Chen
LLLung–Huang Lin
Lung–Huang Lin
FHFu–Chang Hu
Fu–Chang Hu
JLJian–Te Lee
Jian–Te Lee
WLWen–Terng Lin
Wen–Terng Lin
MCMei-Hwei Chang
Mei-Hwei Chang

26 October 2018 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
HCHuey-Ling Chen
Huey-Ling Chen
SWShang-Hsin Wu
Shang-Hsin Wu
SHShu-hao Hsu
Shu-hao Hsu
BLBang-Yu Liou
Bang-Yu Liou
HCHui-Ling Chen
Hui-Ling Chen
MCMei-Hwei Chang
Mei-Hwei Chang
Jaundice is a common symptom of inherited or acquired liver diseases or a manifestation of diseases involving red blood cell metabolism. Recent progress has elucidated the molecular mechanisms of bile metabolism, hepatocellular transport, bile ductular development, intestinal bile salt reabsorption, and the regulation of bile acids homeostasis. The major genetic diseases causing jaundice involve disturbances of bile flow. The insufficiency of bile salts in the intestines leads to fat malabsorption and fat-soluble vitamin deficiencies. Accumulation of excessive bile acids and aberrant metabolites results in hepatocellular injury and biliary cirrhosis. Progressive familial intrahepatic cholestasis (PFIC) is the prototype of genetic liver diseases manifesting jaundice in early childhood, progressive liver fibrosis/cirrhosis, and failure to thrive. The first three types of PFICs identified (PFIC1, PFIC2, and PFIC3) represent defects in FIC1 (ATP8B1), BSEP (ABCB11), or MDR3 (ABCB4). In the last 5 years, new genetic disorders, such as TJP2, FXR, and MYO5B defects, have been demonstrated to cause a similar PFIC phenotype. Inborn errors of bile acid metabolism also cause progressive cholestatic liver injuries. Prompt differential diagnosis is important because oral primary bile acid replacement may effectively reverse liver failure and restore liver functions. DCDC2 is a newly identified genetic disorder causing neonatal sclerosing cholangitis. Other cholestatic genetic disorders may have extra-hepatic manifestations, such as developmental disorders causing ductal plate malformation (Alagille syndrome, polycystic liver/kidney diseases), mitochondrial hepatopathy, and endocrine or chromosomal disorders. The diagnosis of genetic liver diseases has evolved from direct sequencing of a single gene to panel-based next generation sequencing. Whole exome sequencing and whole genome sequencing have been actively investigated in research and clinical studies. Current treatment modalities include medical treatment (ursodeoxycholic acid, cholic acid or chenodeoxycholic acid), surgery (partial biliary diversion and liver transplantation), symptomatic treatment for pruritus, and nutritional therapy. New drug development based on gene-specific treatments, such as apical sodium-dependent bile acid transporter (ASBT) inhibitor, for BSEP defects are underway. Understanding the complex pathways of jaundice and cholestasis not only enhance insights into liver pathophysiology but also elucidate many causes of genetic liver diseases and promote the development of novel treatments.

22 January 2009 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MHMing-Chih Ho
Ming-Chih Ho
GHGuan-Tarn Huang
Guan-Tarn Huang
YTYuk-Ming Tsang
Yuk-Ming Tsang
PLPo-Huang Lee
Po-Huang Lee
DCDing-Shinn Chen
Ding-Shinn Chen
CCChien-Hung Chen
Chien-Hung Chen